Astero Klampatsa

机构：Institute of Cancer Research, Parker Institute for Cancer Immunotherapy · ORCID：0000-0003-0572-502X

发表论文 82 篇 · 总被引 1117 次 · h-index 15

代表论文

• Overcoming efficiency limitations of CAR-T cell therapy in antigen-heterogeneous solid tumors (2024 · Expert Opinion on Biological Therapy · 被引 7)
• Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial (2025 · Nature Communications · 被引 5)
• PD-1 Blockade Mitigates Surgery-Induced Immunosuppression and Increases the Efficacy of Photodynamic Therapy for Pleural Mesothelioma (2025 · Cancer Research Communications · 被引 3)
• Harnessing cellular immunotherapy for cholangiocarcinoma: an integrated roadmap for overcoming resistance (2026 · Frontiers in Immunology · 被引 1)
• Oncofetal antigens as emerging targets in chimeric antigen receptor (CAR)-T cell-based immunotherapies: opportunities and challenges (2026 · Frontiers in Cell and Developmental Biology)
• Supplementary Figure 7 from PD-1 Blockade Mitigates Surgery-Induced Immunosuppression and Increases the Efficacy of Photodynamic Therapy for Pleural Mesothelioma (2025)